In ovarian cancer, BTG1 expression caused a low growth rate, high cisplatin sensitivity, G1 arrest, apoptosis and decreased migration and invasion by down-regulating the expression of PI3K, PKB, Bcl-xL, survivin, VEGF, and MMP-2. Here, BTG1 is linked to ovarian cancer.